NSN 6505-00-063-5570
Part Details | IMIPRAMINE HYDROCHLORIDE TABLETS
6505-00-063-5570
Alternate Parts: NDC00028014010, NDC00028-0140-10, TOFRANIL, NDC00781176410, NDC00781-1764-10, NDC00007032230, NDC00007-0322-30, NDC00182082710, NDC00182-0827-10, NDC00781176410, NDC00781-1764-10, 6505-00-063-5570, 00-063-5570, 6505000635570, 000635570
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JAN 01, 1961 | 00-063-5570 | 30806 ( IMIPRAMINE HYDROCHLORIDE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-00-063-5570
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00028-0140-10 | 3P996 | CIBA-GEIGY CORPCIBA PHARMACEUTICALS DIV |
| TOFRANIL | 97423 | CIBA-GEIGY CORPGEIGY PHARMACEUTICALS DIV |
| NDC00781-1764-10 | 59043 | GENEVA PHARMACEUTICALS INC |
| NDC00007-0322-30 | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICASINC. |
| NDC00182-0827-10 | 63488 | GOLDLINE LABORATORIES INC.DBA GOLDLINE LABORATORIES |
| NDC00781-1764-10 | 0THL4 | SANDOZ INC. |
Technical Data | NSN 6505-00-063-5570
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB25.000 MILLIGRAMS IMIPRAMINE HYDROCHLORIDE |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 TABLETS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | IMIPRAMINE HYDROCHLORIDE TABLETS USP 25 MG 1000 TABLETS/BOTTLE |
